Cargando…

Acinetobacter baumannii response to cefiderocol challenge in human urine

Cefiderocol (CFDC) is a novel chlorocatechol-substituted siderophore antibiotic approved to treat complicated urinary tract infections (cUTI) and hospital-acquired and ventilator-acquired pneumonia (HAP/VAP). Previous work determined that albumin-rich human fluids increase the minimum inhibitory con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimura, Brent, Escalante, Jenny, Tuttobene, Marisel R., Subils, Tomás, Mezcord, Vyanka, Pimentel, Camila, Georgeos, Nardin, Pasteran, Fernando, Rodriguez, Cecilia, Sieira, Rodrigo, Actis, Luis A., Tolmasky, Marcelo E., Bonomo, Robert A., Ramirez, María Soledad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128776/ https://www.ncbi.nlm.nih.gov/pubmed/35610334 http://dx.doi.org/10.1038/s41598-022-12829-7

Ejemplares similares

The Iron Content of Human Serum Albumin Modulates the Susceptibility of Acinetobacter baumannii to Cefiderocol
por: Escalante, Jenny, et al.
Publicado: (2023)

Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport
por: Le, Casin, et al.
Publicado: (2022)

Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
por: Mezcord, Vyanka, et al.
Publicado: (2023)

Human serum albumin (HSA) regulates the expression of histone-like nucleoid structure protein (H-NS) in Acinetobacter baumannii
por: Escalante, Jenny, et al.
Publicado: (2022)

Involvement of the Histone-Like Nucleoid Structuring Protein (H-NS) in Acinetobacter baumannii’s Natural Transformation
por: Le, Casin, et al.
Publicado: (2021)

Histone-like nucleoid-structuring protein (H-NS) regulatory role in antibiotic resistance in Acinetobacter baumannii
por: Rodgers, Deja, et al.
Publicado: (2021)

Antimicrobial activity of the Lacticaseibacillus rhamnosus CRL 2244 and its impact on the phenotypic and transcriptional responses in carbapenem resistant Acinetobacter baumannii
por: Rodriguez, Cecilia, et al.
Publicado: (2023)

Phenotypic and transcriptional analysis of the antimicrobial effect of lactic acid bacteria on carbapenem-resistant Acinetobacter baumannii: Lacticaseibacillus rhamnosus CRL 2244 an alternative strategy to overcome resistance?”
por: Rodriguez, Cecilia, et al.
Publicado: (2023)

Effect of serum albumin, a component of human pleural fluid, on transcriptional and phenotypic changes on Acinetobacter baumannii A118
por: Le, Casin, et al.
Publicado: (2021)

Interaction of Acinetobacter baumannii with Human Serum Albumin: Does the Host Determine the Outcome?
por: Pimentel, Camila, et al.
Publicado: (2021)

Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) Acinetobacter baumannii Representative Strain
por: Pimentel, Camila, et al.
Publicado: (2021)

Genomic Comparative Analysis of Two Multi-Drug Resistance (MDR) Acinetobacter baumannii Clinical Strains Assigned to International Clonal Lineage II Recovered Pre- and Post-COVID-19 Pandemic
por: Traglia, German Matias, et al.
Publicado: (2023)

Staphylococcus aureus α-Toxin Effect on Acinetobacter baumannii Behavior
por: Fernandez, Jennifer S., et al.
Publicado: (2022)

Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii
por: Martinez, Jasmine, et al.
Publicado: (2021)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress
por: Martinez, Jasmine, et al.
Publicado: (2019)

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
por: Cedano, Jose, et al.
Publicado: (2022)

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
por: Ramirez, Maria Soledad, et al.
Publicado: (2020)

2145. Antagonistic Activity of Lacticseibacillus rhamnosus R3 Against Carbapenem-Resistant Acinetobacter baumannii Strain: A Promising Therapeutic Alternative
por: Rodriguez, Cecilia, et al.
Publicado: (2023)

BlsA integrates light and temperature signals into iron metabolism through Fur in the human pathogen Acinetobacter baumannii
por: Tuttobene, Marisel R., et al.
Publicado: (2018)

Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii
por: Raro, Otávio Hallal Ferreira, et al.
Publicado: (2023)

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
por: Dagher, Michael, et al.
Publicado: (2020)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates
por: Pasteran, Fernando, et al.
Publicado: (2021)

Identification of Potential Virulence Factors in the Model Strain Acinetobacter baumannii A118
por: Ramirez, Maria S., et al.
Publicado: (2019)

Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection
por: Mabayoje, Diana A, et al.
Publicado: (2021)

Blue light directly modulates the quorum network in the human pathogen Acinetobacter baumannii
por: Tuttobene, Marisel Romina, et al.
Publicado: (2021)

An Acinetobacter non-baumannii Population Study: Antimicrobial Resistance Genes (ARGs)
por: Baraka, Adam, et al.
Publicado: (2020)

2759. Cefiderocol vs Best Available Therapy for the Treatment of Carbapenem- Resistant Acinetobacter baumannii
por: Daisey, Gabrielle N, et al.
Publicado: (2023)

Draft Genome of the Multidrug-Resistant Acinetobacter baumannii Strain A155 Clinical Isolate
por: Arivett, Brock A., et al.
Publicado: (2015)

2134. Impact of ADC ß-lactamase amino acid variation on cefiderocol (FDC) susceptibility in carbapenem-resistant Acinetobacter baumannii (CRAb) strains
por: Iovleva, Alina, et al.
Publicado: (2023)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates
por: Seifert, Harald, et al.
Publicado: (2023)

Whole-Genome Sequence Analysis of the Naturally Competent Acinetobacter baumannii Clinical Isolate A118
por: Traglia, German M., et al.
Publicado: (2014)

The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii
por: Huang, Fanny, et al.
Publicado: (2020)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates
por: Ballesté-Delpierre, Clara, et al.
Publicado: (2022)

Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in Acinetobacter baumannii
por: Liu, Xiaochen, et al.
Publicado: (2023)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
por: Carcione, Davide, et al.
Publicado: (2021)

666. Outcomes Using Cefiderocol for the Treatment of Acinetobacter baumannii Infections from the PROVE (Real-World Evidence) Study
por: Marcella, Stephen, et al.
Publicado: (2022)

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
por: Quirino, Angela, et al.
Publicado: (2023)

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii
por: Kolesnik-Goldmann, Natalia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjc1qq3sn67qf2r3elqtngiom4